<DOC>
	<DOCNO>NCT01130194</DOCNO>
	<brief_summary>Follicular lymphoma historically consider incurable lymphoma . By combine multiple effective treatment , investigator believe prolong disease-free survival achievable disease . The investigator goal least 60-70 % patient first continuous complete remission 15 year initiation treatment .</brief_summary>
	<brief_title>Immunochemotherapy , Zevalin , Bone Marrow Transplant Follicular Lymphoma</brief_title>
	<detailed_description>Patients receive six cycle combination chemotherapy , C-MOPP-R , typically subcutaneous PORT . This combination chemotherapy last six month . After last dose chemotherapy , patient 2 month treatment holiday prior undergoing stem cell mobilization peripheral blood subcutaneous injection neupogen mozobil . Patients receive Zevalin radioimmunotherapy , follow recovery blood count , typically 3 month later , autologous stem cell transplant .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<criteria>Patients older 18 year age Follicular lymphoma , newly diagnose previously treat 2 previous regimen Relapse disease must great 6 month last chemotherapy Stages II , III IV Eastern Cooperative Group ( ECOG ) performance status 0 1 . If ECOG 24 , poor performance must due lymphoma judged study investigator . Patient sign write informed consent Adequate renal function define glomerular filtration rate ( GFR ) &gt; 60 ml/min Adequate blood count ( absolute neutrophil count ≥ 1,500 , platelet ≥100,000 ) , unless low due lymphomatous involvement bone marrow . No known allergy chemotherapeutic agent No major disable co morbidity Adequate pulmonary function , define correct DLCO great 70 % predict FEV1 ( forced expiratory volume one second , test respiratory function ) great 50 % predict . Adequate hepatic function assess study investigator Adequate cardiac function , define baseline MUGA ( Multiple gate acquisition , test heart function ) &gt; 50 % Stage I follicular lymphoma ECOG performance status ≥ 2 , unless due lymphoma Patient refuse sign write informed consent Poor renal function define GFR &lt; 60ml/min Abnormal liver function assess study investigator Poor bone marrow reserve ( absolute neutrophil count &lt; 1,500 and/or platelet &lt; 100,000 ) attributable lymphomatous involvement bone marrow . Hypersensitivity chemotherapeutic agent Major disable co morbidity like uncontrolled severe HTN ( hypertension ) , active coronary artery disease , liver cirrhosis . Previously diagnose malignancy basal squamous cell carcinoma skin diagnose &lt; 5 year prior . Central nervous system disease History advance cardiac disease ( Active angina , Congestive heart failure LVEF ( leave ventricular ejection fraction ) &lt; 50 % ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>follicular lymphoma</keyword>
	<keyword>radioimmunotherapy</keyword>
	<keyword>rituximab</keyword>
	<keyword>C-MOPP-R</keyword>
	<keyword>autologous transplant</keyword>
</DOC>